The working groups conduct scientific and technical peer reviews and examine other relevant scientific and technical issues within the biocide regulation. All working groups report to the committee and the internal rules of the PCB apply. In order to increase the supply of disinfectant products, the industry has asked the competent authorities to adopt a more flexible “do and tell” principle, which allows the industry to inform the authorities of minor changes to biocides already authorised without having to wait for prior approval. [v] With regard to the requirements of the BPR Article 95 list, some Member States have made it clear that, in view of the current COVID-19 pandemic, disinfectant products are not required to impose this legal requirement, although the supplier of the active substance used in a biocide product or the supplier of the biocide product should in principle be added to the list provided in Article 95. The full list of active substances studied and approved is available on the following link: echa.europa.eu/it/information-on-chemicals/biocidal-active-substances. According to the Italian Ministry of Health, this process can also be used for products authorised in other Member States and/or for products containing active substances with different technical specifications, different locations and/or different production processes. [vi] Therefore, existing industry practices are important to meet applicable legal and technical requirements, particularly when the purpose of a product is not clearly or unreported and products are put on the market without demand. However, the claims themselves are not the only determining factor in understanding whether the product falls under the OR OR or other legislation. It is therefore necessary to assess on a case-by-case basis the procedure to be followed and the relevant legal and technical requirements. EU companies and non-Eu operators (through their EU importers) and regulators are working to make expedited procedures available, eliminating the lengthy pre-market authorisation procedures established by the EU Biocides Regulation (BPR) and other relevant regulations. In this regard, many questions have been raised and the following question arises: (i) what is the legislation in force; (ii) what the appropriate supervisory body is; and (iii) the timely and cost-effective use of legal and technical requirements in practice. For organizational issues related to working group meetings, please contact: pcb-wgs (at) echa.europa.eu [viii] In case of viruses, efficacy must be assessed in accordance with specific technical standards UNI EN 14476 (for skin) and UNI IN 14476 and UNI EN 16777 (for surfaces), as explained in the report of the National Institute of Health on COVID-19/2020. [ix] National Health Institute report on COVID-19 – 19/2020.[v] The following examples have been cited by the European Soap and Detergents Industry Association (AISE): an authorized person who will use the same active substance produced elsewhere, a modification of the source of supply for other (co-formulant) ingredients in products, or a change in the size of the packaging (due to delivery restrictions on certain containers), etc. – caused by the delays of the AU).